0001628280-24-002452.txt : 20240129
0001628280-24-002452.hdr.sgml : 20240129
20240129162738
ACCESSION NUMBER: 0001628280-24-002452
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240129
FILED AS OF DATE: 20240129
DATE AS OF CHANGE: 20240129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leffler Scott J.
CENTRAL INDEX KEY: 0001832406
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26642
FILM NUMBER: 24574066
MAIL ADDRESS:
STREET 1: C/O CLOVER HEALTH INVESTMENTS, CORP.
STREET 2: 3401 MALLORY LANE, SUITE 210
CITY: FRANKLIN
STATE: TN
ZIP: 37067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MYRIAD GENETICS INC
CENTRAL INDEX KEY: 0000899923
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 870494517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 322 NORTH 2200 WEST
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84116
BUSINESS PHONE: 801-584-3600
MAIL ADDRESS:
STREET 1: 322 NORTH 2200 WEST
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84116
4
1
wk-form4_1706563646.xml
FORM 4
X0508
4
2024-01-29
0
0000899923
MYRIAD GENETICS INC
MYGN
0001832406
Leffler Scott J.
322 NORTH 2200 WEST
SALT LAKE CITY
UT
84116
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-01-29
4
A
0
117770
0
A
117770
D
Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.
By: Justin Hunter For: Scott J. Leffler
2024-01-29